Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
AI - search results
If you're not happy with the results, please do another search
Digital learning transformation programme
Alex Drinkall, Communications and Stakeholder Lead, and Martin Sinclair, Programme Lead at Health Education England e-Learning for Healthcare, educate us about the digital learning transformation programme.
SpiralG Project: The first demonstrator of spirulina biorefinery
Here, we learn about the many uses of spirulina algae, and how BBI JU funded project SpiralG is assessing the sustainability and profitability of each spirulina biomass component.
How valuable are randomised controlled trials in reproductive medicine?
Professor Darren Griffin reflects on how patients in fertility clinics should interpret the scientific evidence base when even the experts can’t seem to agree.
EU climate policy on fluorinated greenhouse gases
General Director for Climate Action at the European Commission, Mauro Petriccione explains how the EU climate policy on fluorinated greenhouse gases is working and what its future holds.
Infrastructure and jobs for energy and mobility
Prof Dr Michael Düren from Justus Liebig University Giessen shares his expertise on infrastructure and jobs for both energy and mobility.
Mauro Petriccione – Climate Action European Commission
Mauro Petriccione became Directorate-General for Climate Action at the European Commission in March 2018.
How do you manage and control disparate data?
Here, Brendan Tate takes us on a journey through the reasons why he founded new start-up Cleata Limited, available on the G-Cloud framework.
Recurring hospital-acquired infections: Focus now on COVID-19 – The LumiBio Solution
Andrew Metcalfe, Biotech Specialist at LumiBio discusses the persistent problem of hospital-acquired infections, and why now is the time to focus on reducing COVID- 19 transmission in clinical settings using the LumiBio solution.
Bharat Biotech COVID vaccine shows 81% efficacy at Phase Three
The Bharat Biotech COVID vaccine, COVAXIN, appears to be 81% efficient against the virus in Phase Three of clinical trials.
How to tackle the gender gap in artificial intelligence
To celebrate International Women's Day on the 8th March, a diverse range of women across the AI sphere tell us what it’s like as a woman in the AI industry and provide practical tips for those looking to break-in.
COVID vaccines for mutations will be given faster approval in the UK
Medical regulators will fast-track COVID vaccines for mutations, similar to how seasonal flu shots are developed and released.
Is soil health restricted to agricultural activities?
Aarthi JanakiRaman, Research Manager, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, states that soil health management is no longer restricted to agricultural activities.
7 ways the new post-COVID budget could impact your life
Today (3 March) Chancellor Rishi Sunak unveiled the highly-anticipated 2021 budget, which proposes a variety of policy changes, including extension of the furlough scheme and funding domestic abuse "respite rooms" .
The impact of digital care platforms on healthcare professionals and patients
Dr Simon Bourne, founder and CEO of my mhealth and former COPD lead at Southampton University, examines the digital goals outlined in the NHS long-term plan and the impact of digital patient care platforms on healthcare professionals (HCPs) and patients.
Nano-engineered crystals offer an alternative to metallic particles in fuels
The use of nano-engineered crystals instead of metallic particles in fuels could could open the door to the next generation of transportation fuels.
Tackling vaccination misinformation with local government communications
Karen Steel at Granicus discusses how local government communications could significantly help to stop the spread of COVID misinformation, especially when it comes to vaccinations.
Nick Russell – Xonetic
Nick leads Xonetic. Having worked in both industry and BIG4 / boutique management consultancy environments he has over 20 years of broad experience with a focus on Financial Services, Retail and Higher education sectors. Nick is passionate about helping organisations achieve their full potential by combining the latest cloud...
Technology investments for a remote workforce
Does a remote and distributed workforce change the way you manage your technology? Nick Russell, Managing Director of Xonetic gives us a clue and answers, yes it does.
Are swollen lymph nodes normal after getting the COVID vaccine?
According to radiologists at Massachusetts General Hospital (MGH), swollen lymph nodes after COVID vaccination are a "normal reaction that typically goes away with time".
Cannabidiol, skin homeostasis and acne
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains the potential of CBD and cannabinoids for skin care.
